Indusatumab Biosimilar – Anti-GUCY2C mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameIndusatumab Biosimilar - Anti-GUCY2C mAb - Research Grade
SourceCAS 1497400-26-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsIndusatumab ,5F9,MLN2045,GUCY2C,anti-GUCY2C
ReferencePX-TA1379
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Indusatumab Biosimilar - Anti-GUCY2C mAb - Research Grade

General information on Anti-GUCY2C[Homo sapiens] (Indusatumab ) Monoclonal Antibody

Indusatumab has been invetigated for the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and Advanced Gastrointestinal Carcinoma.

Reviews

  • Vennezza

    Great product!

REVIEW YOUR PRODUCT

Add a review

Your email address will not be published. Required fields are marked *

Related products

Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 180€
Stable Isotope Labelled Indusatumab  Biosimilar – Anti-GUCY2C mAb – Research Grade
SIL

Stable Isotope Labelled Indusatumab Biosimilar – Anti-GUCY2C mAb – Research Grade

PX-TA1379-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products